A Study of Avutometinib for People With Solid Tumor Cancers

Clinical trial NCT06104488 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06104488
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Cancer CNS Tumors CNS Tumor, Adult CNS Tumor, Childhood MAP Kinase Family Gene Mutation NF1 Plexiform Neurofibroma Low-grade Glioma Optic Pathway Gliomas Neuroblastoma Primary Brain Tumor Solid Tumor

Start date: 2023-10-20
Primary completion: 2029-10-20
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.